IN THE NAME OF GOD
description
Transcript of IN THE NAME OF GOD
![Page 1: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/1.jpg)
IN THE NAME OF GOD
![Page 2: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/2.jpg)
LOCAL RECURRENCE OF RCC AFTER PN OR RN
MEHRDAD MOHAMMADI MDENDOUROLOGY &
LAPAROSCOPY
![Page 3: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/3.jpg)
EVALUATION
• the majority of patients with local recurrence also have systemic disease, and a thorough metastatic evaluation should be pursued.
![Page 4: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/4.jpg)
• Surgical resection of isolated local recurrence of RCC after radical nephrectomy should be considered, because it can provide long-term cancer-free status for 30% to 40% of patients.
![Page 5: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/5.jpg)
• Complete resection of abdominal recurrences is often a formidable task because the natural tissue barriers are no longer present and invasion of contiguous organs is common.
• En-bloc resection of adjacent organs is often required, and the risk of morbidity can be substantial.
![Page 6: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/6.jpg)
• Recent data confirm that local recurrence after PN is uncommon, even with a positive surgical margin
• (Permpongkosol et al, 2006; Kwon et al, 2007; Kutikov et al, 2008b; Yossepowitch et al, 2008)
![Page 7: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/7.jpg)
• Most of these local recurrences are distant from the tumor bed and are thus probably a result of unrecognized tumor multicentricity or de novo occurrence rather than true treatment failure.
![Page 8: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/8.jpg)
• Patients with isolated local recurrence after PN can be considered for repeat PN, completion nephrectomy, TA, or AS.
![Page 9: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/9.jpg)
![Page 10: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/10.jpg)
• From 1970 to 1998 the incidence of isolated renal bed recurrence among 1,737 T1-3NOMO unilateral nephrectomy cases was 1.8%.
• There were 30 patients.
![Page 11: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/11.jpg)
Patients were divided into 3 treatment groups of observation (9), therapy excluding surgical extirpation (11) and complete surgical resection alone or in conjunction with additional therapy (10).
![Page 12: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/12.jpg)
• patients who underwent surgical resection had an improved 5-year cause specific survival rate of 51% compared to 18% treated with adjuvant medical therapy and 13% with observation alone.
![Page 13: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/13.jpg)
![Page 14: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/14.jpg)
![Page 15: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/15.jpg)
• retrospectively analyzed 16 patients who were treated surgically at our institution for suspected isolated local renal cell carcinoma recurrence during the last 10 years.
![Page 16: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/16.jpg)
• All patients had undergone extensive staging and had no evidence of distant metastases
with the local recurrence.
![Page 17: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/17.jpg)
• Surgical exploration confirmed carcinoma recurrence in 13 of the 16 cases and all 13 patients underwent complete resection of the local recurrence.
![Page 18: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/18.jpg)
• Three patients were found to have had false-positive computerized tomography findings on surgical exploration.
![Page 19: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/19.jpg)
• Only 2 patients were symptomatic, while in 11 disease had been detected at routine follow up.
![Page 20: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/20.jpg)
• Of the patients 7 died of metastatic disease after a mean survival of 23.1 months (range 4 to 68) following recurrence removal and 6 are alive with a mean survival of 53.0 months
![Page 21: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/21.jpg)
Conclusions
• Careful followup after radical nephrectomy for renal cell carcinoma allows the diagnosis of small local recurrences before they become symptomatic in the majority of cases.
![Page 22: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/22.jpg)
• Although most of these patients will eventually have and die of metastatic disease, an aggressive
surgical approach is justified and can result in prolonged survival.
![Page 23: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/23.jpg)
![Page 24: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/24.jpg)
RECURRENCE SITES
• Renal fossa• Ipsilateral adrenal gland• Ipsilateral retroperitoneal lymph
nodes
![Page 25: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/25.jpg)
Renal fossa
![Page 26: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/26.jpg)
Ipsilateral adrenal gland
![Page 27: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/27.jpg)
Ipsilateral retroperitoneal lymph nodes
![Page 29: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/29.jpg)
TAKE HOME MESSAGE
• Aggressive surgical treatment has frequently been advocated as the best available therapy. Multiple studies have shown that an aggressive surgical approach is effective in prolonging survival.
![Page 30: IN THE NAME OF GOD](https://reader035.fdocuments.net/reader035/viewer/2022070419/56815c56550346895dca5720/html5/thumbnails/30.jpg)
THE END